Spoken Alpha
RMD
RESMED INC
Overview
ResMed designs and manufactures cloud-connected medical devices and software for treating sleep apnea, COPD, and other chronic respiratory conditions, as well as cloud-based software solutions for residential care providers.
RESMED INC is a Healthcare company operating in Medical Instruments & Supplies with a $32.34B market cap.
RMD beat consensus EPS by 0.0% in Q2 FY2027, reported Dec 30, 2026.
24 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-10-04.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2027Earnings2026-10-2914 Q&A exchanges
- Q4 FY2026Earnings2026-08-0614 Q&A exchanges
- Q2 FY2026Earnings2026-01-2910 Q&A exchanges
- Q1 FY2026Earnings2025-10-3010 Q&A exchanges
- Q4 FY2025Earnings2025-07-319 Q&A exchanges
- Q3 FY2025Earnings2025-04-2311 Q&A exchanges
- Q2 FY2025Earnings2025-01-3017 Q&A exchanges
- Q1 FY2025Earnings2024-10-2417 Q&A exchanges
- Q4 FY2024Earnings2024-08-0114 Q&A exchanges
- Q3 FY2024Earnings2024-04-2517 Q&A exchanges
- Q2 FY2024Earnings2024-01-2412 Q&A exchanges
- Q1 FY2024Earnings2023-10-2611 Q&A exchanges
- Q4 FY2023Earnings2023-08-0313 Q&A exchanges
- Q3 FY2023Earnings2023-04-2719 Q&A exchanges
- Q2 FY2023Earnings2023-01-2617 Q&A exchanges
- Q1 FY2023Earnings2022-10-2716 Q&A exchanges
- Q4 FY2022Earnings2022-08-1115 Q&A exchanges
- Q3 FY2022Earnings2022-04-2810 Q&A exchanges
- Q2 FY2022Earnings2022-01-2720 Q&A exchanges
- Q1 FY2022Earnings2021-10-2816 Q&A exchanges
- Q4 FY2021Earnings2021-08-0521 Q&A exchanges
- Q3 FY2021Earnings2021-04-2920 Q&A exchanges
- Q2 FY2021Earnings2021-01-2815 Q&A exchanges
- Q1 FY2021Earnings2020-10-2921 Q&A exchanges
History
Earnings history
- Q2 FY20272026-12-30EPS$2.95 vs $2.92+1.1%Rev— vs ——Finnhub
- Q1 FY20272026-10-28EPS— vs $2.73—Rev— vs ——EODHD
- Q4 FY20262026-08-05EPS$2.95 vs $2.90+1.7%Rev$1.46B vs ——EODHD
- Q3 FY20262026-04-29EPS$2.86 vs $2.80+2.1%Rev$1.43B vs ——EODHD
- Q2 FY20262026-01-28EPS$2.81 vs $2.72+3.3%Rev$1.42B vs ——EODHD
- Q1 FY20262025-10-29EPS$2.55 vs $2.50+2.0%Rev$1.34B vs ——EODHD
- Q4 FY20252025-07-30EPS$2.55 vs $2.48+2.8%Rev$1.35B vs ——EODHD
- Q3 FY20252025-04-22EPS$2.37 vs $2.36+0.4%Rev$1.29B vs ——EODHD
- Q2 FY20252025-01-29EPS$2.43 vs $2.31+5.2%Rev$1.28B vs ——EODHD
- Q1 FY20252024-10-23EPS$2.20 vs $2.04+7.8%Rev$1.22B vs ——EODHD
- Q4 FY20242024-07-31EPS$2.08 vs $2.07+0.5%Rev$1.22B vs ——EODHD
- Q3 FY20242024-04-24EPS$2.13 vs $1.91+11.5%Rev$1.20B vs ——EODHD
- Q2 FY20242024-01-23EPS$1.88 vs $1.78+5.6%Rev$1.16B vs ——EODHD
- Q1 FY20242023-10-25EPS$1.64 vs $1.61+1.9%Rev$1.10B vs ——EODHD
- Q4 FY20232023-08-02EPS$1.60 vs $1.69-5.3%Rev$1.12B vs ——EODHD
- Q3 FY20232023-04-26EPS$1.68 vs $1.59+5.7%Rev$1.12B vs ——EODHD
- Q2 FY20232023-01-25EPS$1.66 vs $1.62+2.5%Rev$1.03B vs ——EODHD
- Q1 FY20232022-10-26EPS$1.51 vs $1.60-5.6%Rev$950.3M vs ——EODHD
- Q4 FY20222022-08-10EPS$1.49 vs $1.46+2.1%Rev$914.7M vs ——EODHD
- Q3 FY20222022-04-27EPS$1.32 vs $1.44-8.3%Rev$864.5M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2027 | 2026-12-30 | $2.95 | $2.92 | +1.1% | — | — | — | Finnhub |
| Q1 FY2027 | 2026-10-28 | — | $2.73 | — | — | — | — | EODHD |
| Q4 FY2026 | 2026-08-05 | $2.95 | $2.90 | +1.7% | $1.46B | — | — | EODHD |
| Q3 FY2026 | 2026-04-29 | $2.86 | $2.80 | +2.1% | $1.43B | — | — | EODHD |
| Q2 FY2026 | 2026-01-28 | $2.81 | $2.72 | +3.3% | $1.42B | — | — | EODHD |
| Q1 FY2026 | 2025-10-29 | $2.55 | $2.50 | +2.0% | $1.34B | — | — | EODHD |
| Q4 FY2025 | 2025-07-30 | $2.55 | $2.48 | +2.8% | $1.35B | — | — | EODHD |
| Q3 FY2025 | 2025-04-22 | $2.37 | $2.36 | +0.4% | $1.29B | — | — | EODHD |
| Q2 FY2025 | 2025-01-29 | $2.43 | $2.31 | +5.2% | $1.28B | — | — | EODHD |
| Q1 FY2025 | 2024-10-23 | $2.20 | $2.04 | +7.8% | $1.22B | — | — | EODHD |
| Q4 FY2024 | 2024-07-31 | $2.08 | $2.07 | +0.5% | $1.22B | — | — | EODHD |
| Q3 FY2024 | 2024-04-24 | $2.13 | $1.91 | +11.5% | $1.20B | — | — | EODHD |
| Q2 FY2024 | 2024-01-23 | $1.88 | $1.78 | +5.6% | $1.16B | — | — | EODHD |
| Q1 FY2024 | 2023-10-25 | $1.64 | $1.61 | +1.9% | $1.10B | — | — | EODHD |
| Q4 FY2023 | 2023-08-02 | $1.60 | $1.69 | -5.3% | $1.12B | — | — | EODHD |
| Q3 FY2023 | 2023-04-26 | $1.68 | $1.59 | +5.7% | $1.12B | — | — | EODHD |
| Q2 FY2023 | 2023-01-25 | $1.66 | $1.62 | +2.5% | $1.03B | — | — | EODHD |
| Q1 FY2023 | 2022-10-26 | $1.51 | $1.60 | -5.6% | $950.3M | — | — | EODHD |
| Q4 FY2022 | 2022-08-10 | $1.49 | $1.46 | +2.1% | $914.7M | — | — | EODHD |
| Q3 FY2022 | 2022-04-27 | $1.32 | $1.44 | -8.3% | $864.5M | — | — | EODHD |
Source: EODHD, Finnhub. RMD reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Michael J FarrellCEO1 yr24 callsCurrent
- Aaron BloomerCFO6 mo1 callCurrent
- Brett SandercockCFO11 yr 9 mo22 callsCurrent
- Kaushik GhoshalChief Commercial Officer, SaaS2 yr 2 mono recorded callsCurrent
- Justin LeongChief Product Officer2 yr 3 mono recorded callsCurrent
- Michael J RiderGlobal General Counsel3 yr 4 mono recorded callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for RMD.
$ curl https://api.spokenalpha.com/v1/companies/RMDFAQ
Frequently asked about RMD
Where can I find RESMED INC's (RMD) earnings call transcripts?
Spoken Alpha indexes RMD's earnings call transcripts at https://spokenalpha.com/companies/RMD. Each call links to attributed speakers and parsed analyst Q&A. RESMED INC's own investor relations page is at https://investor.resmed.com/.
When was RESMED INC's most recent earnings call?
RESMED INC (RMD) held its most recent earnings call on 2026-10-29, covering fiscal Q1 2027.
What sector is RMD in?
RESMED INC (RMD) operates in the Healthcare sector (Medical Instruments & Supplies industry).